We confirmed CD1a-dependence showing that administration of anti-CD1a not only ameliorates cutaneous inflammation but also systemic inflammation as measured by splenomegaly, cellular infiltration and plasma cytokine secretion. Here, CD1A is linked to Splenomegaly.